The fraud estimate provided at yesterday's parliamentary inquiry reframes the debate. If billions of dollars are being lost to fraud, the argument for reform might shift from spending restraint to recovering funds diverted by criminality, but officials essentially admitted that the problem is too big to eliminate by prosecution.
NDIS fraud is so extensive that 'prosecuting our way out of it' is now impractical
April 24, 2026 Latest NewsBioPharmaOther Health
Latest Video
New Stories
-
Pharmac announces plan to revise its recently expanded patient advisory function
August 4, 2026 - - Latest News -
Australian company announces agreement with Lilly to trial lung cancer combination
August 4, 2026 - - Latest News -
The complete absence of patient power and agency makes this a health system outlier
August 4, 2026 - - Latest News -
Arrotex Pharmaceuticals appoints experienced industry executive as CMO
August 4, 2026 - - Latest News -
The risk to patients is that new pricing policies could swamp any benefit from the HTA Review
August 4, 2026 - - Latest News -
Potential merger could create a new global oncology powerhouse
August 3, 2026 - - Latest News -
The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants
August 3, 2026 - - Latest News

